Jie He

6.1k total citations · 1 hit paper
126 papers, 4.5k citations indexed

About

Jie He is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Jie He has authored 126 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 38 papers in Cancer Research and 23 papers in Epidemiology. Recurrent topics in Jie He's work include Cancer-related molecular mechanisms research (26 papers), MicroRNA in disease regulation (24 papers) and Circular RNAs in diseases (16 papers). Jie He is often cited by papers focused on Cancer-related molecular mechanisms research (26 papers), MicroRNA in disease regulation (24 papers) and Circular RNAs in diseases (16 papers). Jie He collaborates with scholars based in China, United States and Canada. Jie He's co-authors include Yaou Zhang, Weidong Xie, Naihan Xu, Nunu Huang, Haoming Xu, Siwei Zhang, Wanqing Chen, Rongshou Zheng, Xiaonong Zou and Ping Zhao and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jie He

120 papers receiving 4.4k citations

Hit Papers

Enterotoxigenic Bacteroides fragilis Promotes Intestinal ... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Jie He
Yi Zeng China
Lin Li China
Wei Xu China
Jie Zhang China
Mei Liu China
Jun Zhu China
Yi Chen China
Hui Gong China
Jie He
Citations per year, relative to Jie He Jie He (= 1×) peers Quancheng Kan

Countries citing papers authored by Jie He

Since Specialization
Citations

This map shows the geographic impact of Jie He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie He more than expected).

Fields of papers citing papers by Jie He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie He. The network helps show where Jie He may publish in the future.

Co-authorship network of co-authors of Jie He

This figure shows the co-authorship network connecting the top 25 collaborators of Jie He. A scholar is included among the top collaborators of Jie He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie He. Jie He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yanqiong, et al.. (2025). Sino–US trade frictions and corporate investment. Finance research letters. 79. 107218–107218. 3 indexed citations
2.
He, Jie, Yifan Zhang, Xiaolan Sun, et al.. (2024). Cerebrospinal Fluid-Derived extracellular Vesicle-Inspired Multifunctional bone regeneration scaffold for cranial defect repair. Chemical Engineering Journal. 504. 158908–158908.
3.
Han, Xiao, Bing Han, Gang Li, et al.. (2023). LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson’s Disease Cell Model. International Journal of Molecular Sciences. 24(13). 11111–11111. 6 indexed citations
4.
Wakelee, Heather A., Moïshe Liberman, Terufumi Kato, et al.. (2023). KEYNOTE-671: Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC.. Journal of Clinical Oncology. 41(17_suppl). LBA100–LBA100. 11 indexed citations
5.
Zhao, Tiansuo, Fanyang Kong, Xiangyu Kong, et al.. (2023). Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 29(24). 5183–5195. 9 indexed citations
7.
He, Jie, et al.. (2023). KLF4 transcription factor in tumorigenesis. Cell Death Discovery. 9(1). 118–118. 78 indexed citations
9.
Lyu, Qing, Nunu Huang, Kunzhe Dong, et al.. (2021). The miR-378/PGC1β/mTOR axis as an alternative mechanism to promote autophagy during adipogenesis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(6). 158921–158921. 1 indexed citations
10.
Xu, Haoming, Youlian Zhou, Jing Xu, et al.. (2021). Inhibition of PD‐1 Protects against TNBS‐Induced Colitis via Alteration of Enteric Microbiota. BioMed Research International. 2021(1). 4192451–4192451. 9 indexed citations
11.
Xu, Haoming, Hongli Huang, Jing Xu, et al.. (2021). Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation. Frontiers in Microbiology. 12. 658292–658292. 53 indexed citations
12.
Wang, Tian, Bing Han, Zhenhua Wang, et al.. (2020). Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo. BMC Complementary Medicine and Therapies. 20(1). 20–20. 87 indexed citations
13.
Hu, Jiaqi, et al.. (2019). Effect of acupoint therapies on chemotherapy-induced nausea and vomiting. Medicine. 98(37). e17109–e17109. 8 indexed citations
14.
Huang, Hong, et al.. (2019). Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota. Journal of Digestive Diseases. 20(8). 401–408. 69 indexed citations
15.
He, Jie, Qian Liang, Jia‐Yin Tang, et al.. (2016). LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. Cancer Discovery. 6(7). 784–801. 321 indexed citations
16.
He, Jie, Xue Sun, Yue Ding, et al.. (2016). Gender Differences in Risks of Coronary Heart Disease and Stroke in Patients with Type 2 Diabetes Mellitus and Their Association with Metabolic Syndrome in China. International Journal of Endocrinology. 2016. 1–7. 16 indexed citations
17.
Wang, F., Haoxiang Zhang, Naihan Xu, et al.. (2016). A novel hypoxia-induced miR-147a regulates cell proliferation through a positive feedback loop of stabilizing HIF-1α. Cancer Biology & Therapy. 17(8). 790–798. 25 indexed citations
18.
Chen, Wanqing, Rongshou Zheng, Siwei Zhang, et al.. (2012). Lung cancer incidence and mortality in China, 2009. Thoracic Cancer. 4(2). 102–108. 287 indexed citations
19.
Zhang, Siwei, et al.. (2012). Incidence and mortality of breast cancer in China, 2008. Thoracic Cancer. 4(1). 59–65. 18 indexed citations
20.
Xie, Weidong, Fu Li, Qing Lv, et al.. (2011). MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the coding region of mouse pleiotrophin. FEBS Letters. 585(20). 3303–3309. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026